PPD02.02 Tepotinib + Gefitinib in Patients with EGFR-Mutant NSCLC with MET Amplification (METamp): Final Analysis of INSIGHT
Year: 2023
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: R. OHara, C. Kin Liam, A. Rozila Ahmad, T.-C. Hsia, J. Zhou, D.-W. Kim, R. Andrew Soo, Y. Cheng, S. Lu, S. Won Shin, J. Chih-Hsin Yang, Y. Zhang, J. Zhao, R. Bruns, A. Johne, Y.-L. Wu
Institutions: Merck Healthcare KGaA, Darmstadt (Germany), University of Malaya, China Medical University Hospital, First Affiliated Hospital Zhejiang University, Seoul National University Hospital, National University Cancer Institute, Singapore, Jilin Province Tumor Hospital, Shanghai Chest Hospital, Korea University Anam Hospital, National Taiwan University Hospital, Zhejiang Cancer Hospital, Peking University Cancer Hospital, Merck KGaA, Darmstadt (Germany), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4318303054